SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103. A total of 88 filers reported holding SYNAGEVA BIOPHARMA CORP in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $4,034,000 | +40240.0% | 41,356 | +39665.4% | 0.00% | – |
| Q4 2014 | $10,000 | +42.9% | 104 | 0.0% | 0.00% | – |
| Q3 2014 | $7,000 | -99.2% | 104 | -98.8% | 0.00% | -100.0% |
| Q2 2014 | $927,000 | +140.8% | 8,851 | +90.5% | 0.00% | – |
| Q1 2014 | $385,000 | +654.9% | 4,645 | +491.0% | 0.00% | – |
| Q4 2013 | $51,000 | -96.1% | 786 | -96.2% | 0.00% | -100.0% |
| Q3 2013 | $1,299,000 | -46.2% | 20,512 | -64.3% | 0.00% | -50.0% |
| Q2 2013 | $2,416,000 | – | 57,512 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 10,660,432 | $989,182,000 | 10.10% |
| BB BIOTECH AG | 1,130,476 | $104,897,000 | 3.40% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 80,000 | $7,423,000 | 3.31% |
| Opus Point Partners Management, LLC | 20,002 | $1,856,000 | 1.84% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 3,847,094 | $356,972,000 | 1.77% |
| SECTORAL ASSET MANAGEMENT INC | 363,884 | $33,765,000 | 1.52% |
| Cormorant Asset Management, LP | 100,000 | $9,279,000 | 1.43% |
| Tekla Capital Management LLC | 223,020 | $20,694,000 | 0.97% |
| Lamond Capital Partners LLC | 15,390 | $1,428,000 | 0.94% |
| Squarepoint Ops LLC | 6,700 | $622,000 | 0.60% |